The cosmonaut programme, the Mir anecdote, and the line between them

The paper trail opens in 1980 with a synthesis paper from Glozman, Morozov, Zhmurenko and Zagorevskii — the All-Union Research Chemical-Pharmaceutical Institute lineage — and continues in 1983 with the first pharmacological description, “a new phenyl analog of piracetam — 4-phenylpiracetam”, sharing three authors with the synthesis paper.[2][3]

The development site and purpose are stated in two independent peer-reviewed sources. Voronina’s 2023 review in the Neurochemical Journal: phenylpiracetam “was developed at the Institute of Biomedical Problems as a new generation psychostimulant that can increase the mental and physical performance of astronauts at various stages of space flights”. The IBMP was the Soviet space-medicine institute — the organisation responsible for crew health and performance in orbit. Veinberg and colleagues at the Latvian Institute of Organic Synthesis corroborate from the chemistry side: the molecule “was originally designed as a nootropic drug for the sustenance and improvement of the physical condition and cognition abilities of Soviet space crews”.[5][6]

Later Russian Phenotropil publications are co-authored by V.I. Akhapkina — consistent with secondary accounts that psychopharmacologist Valentina Akhapkina led the programme at IBMP. Her patent would sit at the centre of a Russian market battle decades later, when Pharmstandard had it invalidated in 2020 and launched the generic Actitropil.

One documented radiation link exists: a 2016 study tested phenotropil with palonosetron against the nausea-vomiting-diarrhoea stage of acute radiation syndrome in rats and dogs — framed explicitly as preserving work capacity in people who would respond to future radiation accidents.[41]

The widely quoted story: pilot-cosmonaut Aleksandr Serebrov is said to have described phenylpiracetam as part of the Soyuz/Mir onboard medical kit during his 197-day Mir expedition, calling it “the equalizer of the whole organism”.

As of this site’s 2026-08-15 verification pass, that quote traces to exactly one source: a Russian pharmaceutical-marketing article (“Phenotropil: natural leadership”), archived in 2017 and cited by Wikipedia. No Roscosmos or IBMP document, no news archive and no primary paper confirming that any cosmonaut carried or took the drug in flight was located. The development FOR cosmonaut performance is documented by two independent peer-reviewed sources; use BY cosmonauts in flight is not documented anywhere we could verify. This site prints the anecdote as an anecdote — attractive, plausible, and unconfirmed.

Phenylpiracetam is sometimes said to have been administered to Chernobyl liquidators. Our pass found no source for that claim: not in PubMed, and not in any review read. The closest documented link is the 2016 animal study above — a real paper about preparing future accident responders, not a record of human use at Chernobyl. Where the claim appears elsewhere, it travels without a citation.[41]

The molecule’s second life was civilian and Russian: open clinical studies through the 2000s and 2010s in stroke rehabilitation, epilepsy, asthenia and encephalopathy, and a prescription market built around the Phenotropil brand. The exact Russian registration date — often stated as 2003 — was not verified against the State Register of Medicines, and this site marks it as unconfirmed. Meanwhile the sport world had already moved: in 1998 carphedon became the first nootropic on the prohibited list, one year before a Korean laboratory published a urine detection method written expressly for doping control.[29][4]

The West’s one industrial chapter belongs to Merz Pharmaceuticals, which characterised the R-enantiomer as MRZ-9547 — an atypical dopamine reuptake inhibitor — for fatigue and motivational deficits in Parkinson’s disease and depression. The last peer-reviewed activity is 2014; the programme’s later fate is unknown.[8]

The pattern this page teaches: carphedon’s true history is strong enough. It does not need the legends — and the legends do not survive verification.